Ignite Creation Date:
2025-12-25 @ 4:34 AM
Ignite Modification Date:
2025-12-26 @ 3:36 AM
Study NCT ID:
NCT00848718
Status:
COMPLETED
Last Update Posted:
2019-11-12
First Post:
2009-02-19
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Phase I Study of MK-2206 in Combination With Standard Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors (MK-2206-003)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-03-17
Start Date Type:
ACTUAL
Primary Completion Date:
2011-05-19
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-05-17
Completion Date Type:
ACTUAL
First Submit Date:
2009-02-19
First Submit QC Date:
None
Study First Post Date:
2009-02-20
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-10-14
Results First Submit QC Date:
None
Results First Post Date:
2019-11-12
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-11-08
Last Update Post Date:
2019-11-12
Last Update Post Date Type:
ACTUAL